Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
678.00    -7.00 (-1.02%)
Bid:
665.00
Ask:
678.00
Spread: 13.00 (1.955%)
Market Cap: £658.48m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

Interim Management Statement

23 Jan 2009 07:00

RNS Number : 1292M
Acal PLC
23 January 2009
Β 

ο»Ώ

FOR RELEASE

7.00 AM

23Β JANUARY 2009

ACAL plcΒ 

SECOND INTERIM MANAGEMENT STATEMENT

PERIOD COMMENCING 1Β OCTOBERΒ 2008

Acal plc is today issuing its second Interim Management StatementΒ for the year ending 31 March 2009,Β which covers the period commencing 1Β OctoberΒ 2008 to date and includes trading for the nine months ended 31 December 2008.

Current trading

As we have reported in earlier statements, our markets have become increasingly difficult over the last six months.

AlthoughΒ the Group's sales for the quarter ended 31 December 2008 were slightly ahead of the corresponding quarter to December 2007,Β marginsΒ within theΒ ElectronicsΒ DivisionΒ wereΒ adversely impacted by theΒ decline in sterling over the quarter.Β Β Within the Supply ChainΒ DivisionΒ (formerly Parts Services), the new management teamΒ has commenced the integration of Service Source Europe andΒ is workingΒ toΒ resolve ongoingΒ contractΒ operating losses.

In light of current trading levels, one-offΒ foreignΒ exchange lossesΒ and the cost ofΒ implementingΒ furtherΒ efficiencies, the GroupΒ resultΒ for the year ending 31 March 2009Β will beΒ below market expectations.

Following theΒ netΒ benefitΒ from theΒ sale ofΒ MessageLabs GroupΒ and the acquisition of Service Source Europe Limited, theΒ groupΒ retains significant net cashΒ despite increasing pressures on working capital.Β 

With the appointment ofΒ Nick Jefferies as GroupΒ Chief ExecutiveΒ on 5 January 2009,Β we will be carrying out a comprehensive review of Acal's business and strategy. The Board remains confidentΒ in the opportunities for the development of the business.

The following materialΒ events orΒ transactions,Β each of which hasΒ been previously reported,Β impacted the Group during the period covered by this Interim Management Statement.

MessageLabs Group Limited

The sale of MessageLabs Group Limited to Symantec was completed on 14 November 2008. The total consideration receivable by Acal for its 3.95% investment is Β£16.2 million of which Β£15.1 million was received on that date. The balance is retained in escrow and will be returned to Acal if there are no warranty claims within a 12 month period.

Service Source Europe Limited

The acquisition of 75% of Service Source Europe Limited (SSE) was completed on January 9 2009Β for a consideration in cash of Β£1.85 million. In addition, Acal subscribed for deferred shares in SSE with a total nominal value of Β£346,625 in cash to enable SSE's preference shares to be redeemed.

Β Β 

For further information:-

Nicholas JefferiesΒ ~Β Chief Executive

Malcolm CooperΒ ~ Finance Director

Brian Coleman-Smith/JamesΒ Verstringhe

Cubitt ConsultingΒ 

01483 544500

01483 544500

020 7367 5100

Notes to the Interim Management Statement

(a) This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Acal plc, as a body, in order to meet the requirements of the UK Listing Authority’s Disclosure and Transparency Rules.
Β 
(b) The Interim Management Statement may contain forward-looking statements which:

Β 

Β§ have been made by the directors in good faith based on the information available to them up to the time of their approval of this statement; and
Β 
Β§ should be treated with caution due to inherent uncertainties, which are beyond Acal’s ability to control or estimate precisely and include both economic and business risk factors, underlying such forward looking information.

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components,Β Supply ChainΒ Services and Medical and Scientific products. Organised into three divisions, Acal has 15Β principal trading companies of which 8 are in Continental Europe andΒ 7Β in theΒ UK.

Acal is nowΒ Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both theΒ UKΒ andΒ South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. TheΒ Supply ChainΒ division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market.Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBCGDBXGDGGCD
Date   Source Headline
25th May 20069:26 amRNSDisposal
12th May 20061:44 pmRNSHolding(s) in Company
10th May 20067:00 amRNSNotice of Results
18th Jan 20065:51 pmRNSBlocklisting Interim Review
22nd Dec 200511:02 amRNSHolding(s) in Company
20th Dec 200512:43 pmRNSHolding(s) in Company
15th Dec 200510:30 amRNSHolding(s) in Company
21st Nov 200511:27 amRNSHolding(s) in Company
7th Nov 20057:00 amRNSNotice of Results
3rd Nov 200510:00 amRNSHolding(s) in Company
2nd Nov 200510:58 amRNSHolding(s) in Company
28th Sep 20057:00 amRNSAdoption of IFRS
26th Sep 200511:09 amRNSTrading Statement
31st Aug 200512:10 pmRNSHolding(s) in Company
20th Jul 20052:59 pmRNSDoc re. Results of AGM
4th Jul 200510:26 amRNSBlocklisting Interim Review
30th Jun 20054:26 pmRNSDirector Shareholding
30th Jun 20054:24 pmRNSDirector Shareholding
24th Jun 200511:28 amRNSDirector Shareholding
23rd Jun 20055:58 pmRNSDirector Shareholding
22nd Jun 20052:19 pmRNSDoc re. Report & Accounts
6th Jun 200512:43 pmRNSDividend Declaration
6th Jun 20057:00 amRNSFinal Results
10th May 200511:18 amRNSHolding(s) in Company
4th May 20057:00 amRNSNotice of Results
29th Mar 20057:00 amRNSDirectorate Change
24th Jan 20054:30 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.